Organogenesis Holdings Inc. (ORGO) CEO Gary S. Gillheeney, Sr. on Q4 2019 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q4: 2020-03-09 Earnings Summary

EPS of -$0.04 beats by $0.05
 | Revenue of $74.65M beats by $3.09M

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2019 Earnings Conference Call March 9, 2020 5:00 PM ET

Company Participants

Gary S. Gillheeney, Sr. - President & Chief Executive Officer
Tim Cunningham - Chief Financial Officer

Conference Call Participants

Matt Miksic - Credit Suisse
Richard Newitter - SVB Leerink
Ryan Zimmerman - BTIG
Steven Lichtman - Oppenheimer & Company

Operator

Good afternoon, ladies and gentlemen, and welcome to the Fourth Quarter 2019 Earnings Conference Call for Organogenesis Holdings Inc. At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded and the record will be available on the company's website for replay shortly.

Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company's filings with the Securities and Exchange Commission, including Item 1A Risk Factors of the company's Form 10-K for the year ending December 31, 2019, which was filed this afternoon.

You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Although it is – may voluntary do so from time to time, the company undertakes no commitment to update or revise the forward-looking statements whether as a result of new information, further events or otherwise except as required by applicable securities laws.

This call will also include references to certain financial measures that are not calculated in accordance with the generally accepted accounting principles or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and present in accordance with

Recommended For You

About ORGO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ORGO